Blood Podcast How PAR2 signaling drives thrombo-inflammation; pretransfusion hemoglobin levels linked to survival in beta-thalassemia; etoposide is better than its reputation in primary HLH
Mar 7, 2024
Exploring PAR2 signaling in thrombo-inflammation, the correlation between pre-transfusion hemoglobin levels and survival in beta-thalassemia, and the benefits of etoposide in primary HLH treatment. Delving into intricate signaling pathways, mortality risk factors, and advancements in HLH therapy.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Exploring PAR2 Signaling Pathways in Inflammatory Cell Recruitment
02:26 • 3min
Exploring protease signaling in disease models and thalassemia patient mortality risk
05:28 • 3min
Impact of Pre-Transfusion Hemoglobin Levels on Mortality in Beta-Thalassemia Patients
08:03 • 4min
Advancements in Primary HLH Treatment
12:18 • 5min